search
Back to results

Effect of Transcranial Direct Current Stimulation (tDCS) and Probiotic Supplementation in Overweight Adults

Primary Purpose

Overweight and Obesity

Status
Recruiting
Phase
Not Applicable
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Probiotic Blend Capsule
tDCS
Sham tDCS
Sponsored by
University of Tehran
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overweight and Obesity focused on measuring transcranial direct current stimulation, obesity, overweight, impulse control

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: BMI over 25 Higher than normal fat level Exclusion Criteria: Pregnancy Breastfeeding Smoking more than 10 cigarettes a day Excessive consumption of alcohol Suffering from chronic cardiovascular and kidney diseases Chronic digestive diseases such as celiac disease, Chronic inflammatory bowel diseases such as colitis, intestinal surgery, cancer, etc. Suffering from acute and chronic diarrhea in the last one month Taking antibiotics in two months before the start of the study, Continuous use of prebiotic and probiotic products and drugs in one month before the start of the intervention Frequent use of antibiotics during the last month before the start of the intervention Taking weight loss medications and following a special slimming diet in the last 3 months before the intervention. History of epilepsy and seizures, stroke, Use of pacemaker Presence of metal implanted in the scalp or brain, Presence of skin lesions at the tDCS stimulation site, and history of head injury or brain surgery. Brain disorders and long-term and chronic use of neuropsychiatric drugs.

Sites / Locations

  • Atieh neuroscience centerRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Sham Comparator

Active Comparator

Arm Label

Active tDCS over the dorsolateral prefrontal cortex (DLPFC)

Active tDCS over the ventromedial prefrontal cortex (VMPFC)

Sham tDCS Stimulation

Probiotic supplementation

Arm Description

In this group, participants will receive active 2 milliampere (mA) tdcs over the DLPFC (anode on F3 and cathode onF4) for 20 minutes.

In this group, participants will receive active 2 mA tdcs over the VMPFC (anode on Fpz and cathode on Cz) for 20 minutes.

In this group, participants will receive sham tDCS which will ramp up for 30 s at the beginning of the session and then ramp down and be switched off during the 20-minute stimulation session.

In this group, participants will consume 2 probiotic supplements (The synbiotics family) daily, for one month.

Outcomes

Primary Outcome Measures

Body analysis test
This is a technique to determine the percentage of body mass that is fat compared to muscle. It can also indicate where the fat and muscle are carried within the body.
Impulsive Behavior Scale Questionnaire measuring Urgency, Premeditation (lack of), Perseverance (lack of), and Sensation seeking (UPPS)
This is a self-report tool that assesses five subscales (urgency, premeditation, perseverance, sensation seeking, and positive urgency) that are used to measure five distinct dimensions of impulsive behavior; each scale ranging from 4 to 16); Higher scores represent worse outcome.
Eating attitudes Test (EAT-26)
This tool is used to identify the presence of "eating disorder risk" based on attitudes, feelings and behaviours related to eating. The total score (between 0 and 78) provides an overall risk score, where higher scores indicating greater risk of an eating disorder.
Balloon analogue risk task (BART)
BART is a computerized decision-making task that is used to assess risk-taking behavior. The BART simulates a real-world situation, involving actual risky behavior, where taking a risk up until a certain point yields a reward.
Tangney self-control questionnaire (Form 36)
This is a self-report measurement to assess individual differences in traits of self-control. Scores range from 0 to 144 with higher scores representing worse outcome.

Secondary Outcome Measures

Full Information

First Posted
September 6, 2023
Last Updated
September 13, 2023
Sponsor
University of Tehran
Collaborators
University of Messina, Tabriz University
search

1. Study Identification

Unique Protocol Identification Number
NCT06035718
Brief Title
Effect of Transcranial Direct Current Stimulation (tDCS) and Probiotic Supplementation in Overweight Adults
Official Title
Comparing the Effectiveness of Transcranial Direct Stimulation (tDCS) and Probiotic Supplementation on Risky Decision-making, Impulsivity, Self-control, and Food Selection in Overweight Adults
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2023 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Tehran
Collaborators
University of Messina, Tabriz University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the current study is to investigate and compare the effectiveness of probiotic supplementation and tDCS stimulation on risky decision-making related to food choices in overweight people. Considering the relatively established communication and interaction between the gut-brain-microbiome axis, the investigators expect that transcranial direct current stimulation and probiotic supplementation can both improve decision-making (decrease risky and impulsive decisions) and increase self-control in overweight people.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight and Obesity
Keywords
transcranial direct current stimulation, obesity, overweight, impulse control

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active tDCS over the dorsolateral prefrontal cortex (DLPFC)
Arm Type
Experimental
Arm Description
In this group, participants will receive active 2 milliampere (mA) tdcs over the DLPFC (anode on F3 and cathode onF4) for 20 minutes.
Arm Title
Active tDCS over the ventromedial prefrontal cortex (VMPFC)
Arm Type
Active Comparator
Arm Description
In this group, participants will receive active 2 mA tdcs over the VMPFC (anode on Fpz and cathode on Cz) for 20 minutes.
Arm Title
Sham tDCS Stimulation
Arm Type
Sham Comparator
Arm Description
In this group, participants will receive sham tDCS which will ramp up for 30 s at the beginning of the session and then ramp down and be switched off during the 20-minute stimulation session.
Arm Title
Probiotic supplementation
Arm Type
Active Comparator
Arm Description
In this group, participants will consume 2 probiotic supplements (The synbiotics family) daily, for one month.
Intervention Type
Drug
Intervention Name(s)
Probiotic Blend Capsule
Intervention Description
By a probiotic blend capsule a specific product is intended which contains the following: Lactobacillus rhamnosus Lactobacillus plantarum Lactobacillus casei Lactobacillus helveticus Lactobacillus acidophilus Lactobacillus bulgaricus Lactobacillus gasseri Bifidobacterium bifidum Bifidobacterium lactis Bifidobacterium breve Bifidobacterium longum Streptococcus thermophile Fructooligosaccharides (FOS).
Intervention Type
Device
Intervention Name(s)
tDCS
Intervention Description
Using a tDCS device, a mild direct electric current is going to be non-invasively administered to the brain using rubber electrodes placed over the scalp.
Intervention Type
Device
Intervention Name(s)
Sham tDCS
Intervention Description
Using a tDCS device, a mild direct electric current is going to be non-invasively administered to the brain using rubber electrodes placed over the scalp. At this arm the electric current will be applied for a very short time (30 s) after which the device will turn off, thus providing the initial tingling sensation over the scalp but not interfering with the ongoing brain activity.
Primary Outcome Measure Information:
Title
Body analysis test
Description
This is a technique to determine the percentage of body mass that is fat compared to muscle. It can also indicate where the fat and muscle are carried within the body.
Time Frame
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Title
Impulsive Behavior Scale Questionnaire measuring Urgency, Premeditation (lack of), Perseverance (lack of), and Sensation seeking (UPPS)
Description
This is a self-report tool that assesses five subscales (urgency, premeditation, perseverance, sensation seeking, and positive urgency) that are used to measure five distinct dimensions of impulsive behavior; each scale ranging from 4 to 16); Higher scores represent worse outcome.
Time Frame
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Title
Eating attitudes Test (EAT-26)
Description
This tool is used to identify the presence of "eating disorder risk" based on attitudes, feelings and behaviours related to eating. The total score (between 0 and 78) provides an overall risk score, where higher scores indicating greater risk of an eating disorder.
Time Frame
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Title
Balloon analogue risk task (BART)
Description
BART is a computerized decision-making task that is used to assess risk-taking behavior. The BART simulates a real-world situation, involving actual risky behavior, where taking a risk up until a certain point yields a reward.
Time Frame
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Title
Tangney self-control questionnaire (Form 36)
Description
This is a self-report measurement to assess individual differences in traits of self-control. Scores range from 0 to 144 with higher scores representing worse outcome.
Time Frame
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: BMI over 25 Higher than normal fat level Exclusion Criteria: Pregnancy Breastfeeding Smoking more than 10 cigarettes a day Excessive consumption of alcohol Suffering from chronic cardiovascular and kidney diseases Chronic digestive diseases such as celiac disease, Chronic inflammatory bowel diseases such as colitis, intestinal surgery, cancer, etc. Suffering from acute and chronic diarrhea in the last one month Taking antibiotics in two months before the start of the study, Continuous use of prebiotic and probiotic products and drugs in one month before the start of the intervention Frequent use of antibiotics during the last month before the start of the intervention Taking weight loss medications and following a special slimming diet in the last 3 months before the intervention. History of epilepsy and seizures, stroke, Use of pacemaker Presence of metal implanted in the scalp or brain, Presence of skin lesions at the tDCS stimulation site, and history of head injury or brain surgery. Brain disorders and long-term and chronic use of neuropsychiatric drugs.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Abed Hadipour Lakmehsari, PhD
Phone
3883041384
Ext
+39
Email
ahadipourlakmehsari@unime.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marzieh Heysiattalab, PhD
Organizational Affiliation
University of Tabriz
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Reza Kazemi, PhD
Organizational Affiliation
University of Tehran
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Sara Derafsheh, MSC
Organizational Affiliation
University of Tabriz
Official's Role
Principal Investigator
Facility Information:
Facility Name
Atieh neuroscience center
City
Tehran
ZIP/Postal Code
1969713663
Country
Iran, Islamic Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Reza Kazemi, PHD
Phone
009802184012121
Email
rezakazemi@ut.ac.ir
First Name & Middle Initial & Last Name & Degree
Sara Derafsheh, MSC

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of Transcranial Direct Current Stimulation (tDCS) and Probiotic Supplementation in Overweight Adults

We'll reach out to this number within 24 hrs